Vanda Slams US Federal Circuit In Teva, Apotex Hetlioz Supreme Court Petition
Federal Circuit Applied ‘Improper Standard’ In Obviousness Conclusion, Vanda Says
Serial litigator Vanda Pharmaceuticals has followed through on its pledge to take its patent-infringement loss to Teva and Apotex over its Hetlioz sleep-disorder brand all the way to the US Supreme Court.
